Search

everythinglearnresearchcommunity

for

Search:↓

Dandruff scalps have unstable microbes, more Malassezia, less Cutibacterium, and targeting Lactobacillus may help.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Human hair-derived particles can effectively carry and release the cancer drug Paclitaxel in a pH-sensitive manner, potentially targeting cancer cells while sparing healthy ones.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

Male hormones can cause hair loss, but treatments like Minoxidil and Finasteride can help, and targeting TGF-B1 could be a future solution.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

Methotrexate, resveratrol, and curcumin may help treat alopecia areata by targeting immune cells.

Polygonum multiflorum, especially emodin, may help treat hair loss by targeting specific proteins, offering a new approach beyond traditional therapies.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

The study found that aging hair follicle stem cells change behavior, leading to hair loss, but drugs targeting these cells may help restore hair growth.

Collagen type XVII α1 decreases with age, leading to skin aging, but targeting microRNA-203b-3p may help maintain its levels and improve skin health.

Hirsutism, excessive hair growth in women, is often caused by polycystic ovarian syndrome and is treated by targeting the cause, lifestyle changes, and medication.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Educational efforts can reduce harmful chemical exposure from hair products in pregnant Women of Color.

A protein called FGF9 helps regenerate hair follicles in mice after skin damage, and increasing FGF9 could potentially help human hair growth.

The K15 promoter effectively targets stem cells in the hair follicle bulge.

Certain drugs that block specific enzymes can help treat prostate diseases.

α-mangostin nanoparticles improved acne with minimal irritation.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Nonimmunosuppressive cyclosporines might treat skin diseases by affecting cell growth.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Olorofim effectively treats fungal skin infections.